Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis-Reference-Cited by-同舟云学术

Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis

Published:1990-10 Issue:4 Volume:117 Page:556-560
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Montini Giovanni,Zacchello Graziella,Baraldi Eugenio,Zanconato Stefania,Suppiej Agnese,Fabris Fabrizio,Andreetta Barbara,Pavanello Luigi,Zacchello Franco

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference21 articles.

1. The anaemia of chronic renal failure: pathophysiology and the effects of recombinant human erythropoietin;Eschbach;Kidney Int,1989

2. Exercise tolerance in end-stage renal disease;Zanconato;Child Nephrol Urol,1990

3. Bleeding in renal failure;Remuzzi;Lancet,1988

4. Recombinant human erythropoietin: implications for nephrology;Eschbach;Am J Kidney Dis,1988

5. Pathogenesis of cerebral atrophy in uraemia;Savazzi;Nephron,1988

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2023

2. Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review;Clinical Kidney Journal;2022-02-26

3. Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS);Pediatric Nephrology;2019-11-10

4. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2016

5. Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease;Pediatric Nephrology;2013-09-05